Rain Therapeutics is a operator of a clinical stage biotechnology company.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Fremont
State: California
Zip:
Country: United States
Rain Therapeutics develops targeted therapies for patients with cancer. We begin by identifing cancers with a single, and clear, oncogenic driver and evaluating sub-populations of cancer populations with an unmet need, where standards of care are ineffective. Our global scientific and thought-leader network drives our asset and technology identification to match these cancers with small molecule therapeutics targeted at treating specific cancer mutations.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/22/2021
IPO Valuation:
$460M
Ticker Symbol:
RAIN
IPO Price:
$17/share
Amount Raised:
$125M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Series A | 3 | $18.4M |
Biotechnology Value Fund Perceptive Advisors University of Auckland Inventors Fund Biotechnology Value Fund Perceptive Advisors University of Auckland Inventors Fund |
9/2020 | Series B | 7 | $63M |
Boxer Capital BVF Partners Cormorant Asset Management Janus Henderson Investors Logos Capital Perceptive Advisors Samsara BioCapital Boxer Capital BVF Partners Cormorant Asset Management Janus Henderson Investors Logos Capital Perceptive Advisors Samsara BioCapital |
12/2017 | Convertible Note | $1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|